• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用低剂量率照射鉴别人类肿瘤的放射反应性

Discrimination of human tumor radioresponsiveness using low-dose rate irradiation.

作者信息

Björk-Eriksson T, West C, Karlsson E, Mercke C

机构信息

Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.

出版信息

Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):1147-53. doi: 10.1016/s0360-3016(98)00287-9.

DOI:10.1016/s0360-3016(98)00287-9
PMID:9869242
Abstract

PURPOSE

Evaluation of the theoretical and practical value of using low-dose rate (LDR) irradiation to increase the resolution of radiosensitivity testing of primary human tumors using clonogenic assays.

METHODS AND MATERIALS

Fourteen human tumor cell lines were assessed for surviving fraction at 2-8 Gy (SF2-SF8) using low-dose rate irradiation and a clonogenic assay. Further data were collected from the literature for 64 low-dose rate irradiation survival curves from human tumor cell lines. The data were grouped into five different radioresponsiveness categories (A-E). An analysis was made of the ability of the graded survival levels to discriminate between the different radioresponse groups and compared with previous analyses for high-dose rate SF2. Fifteen human cervical carcinoma specimens were analysed for SF2 and SF3.5 following high- and low-dose rate irradiation.

RESULTS

Low-dose rate irradiation increased the spread of tumor cell line radiosensitivity data and the ability to discriminate between radioresponse groups was greater at low than at high-dose rates. Using low-dose rate irradiation on primary tumor specimens and a soft agar clonogenic assay decreased the success rate in obtaining data. The latter dropped from 70% for high-dose rate SF2 to 51% for low-dose rate SF3.5.

CONCLUSIONS

The work on cell lines illustrates that low-dose rate irradiation does improve the ability of clonogenic radiosensitivity measurements to discriminate between tumors of different radioresponsiveness groups. However, using low-dose rate irradiation on primary human tumors with a soft agar clonogenic assay was not practical because of reducing the success rate for obtaining data for radiosensitivity measurements.

摘要

目的

评估使用低剂量率(LDR)照射提高原发性人类肿瘤放射敏感性测试分辨率的理论和实用价值,该测试采用克隆形成试验。

方法和材料

使用低剂量率照射和克隆形成试验评估14种人类肿瘤细胞系在2 - 8 Gy剂量下的存活分数(SF2 - SF8)。从文献中收集了64条来自人类肿瘤细胞系的低剂量率照射存活曲线的进一步数据。数据被分为五个不同的放射反应类别(A - E)。分析分级存活水平区分不同放射反应组的能力,并与之前对高剂量率SF2的分析进行比较。对15例人类宫颈癌标本进行高剂量率和低剂量率照射后的SF2和SF3.5分析。

结果

低剂量率照射增加了肿瘤细胞系放射敏感性数据的离散度,且低剂量率下区分放射反应组的能力高于高剂量率。对原发性肿瘤标本使用低剂量率照射和软琼脂克隆形成试验会降低获取数据的成功率。后者从高剂量率SF2的70%降至低剂量率SF3.5的51%。

结论

细胞系研究表明,低剂量率照射确实提高了克隆形成放射敏感性测量区分不同放射反应组肿瘤的能力。然而,对原发性人类肿瘤使用低剂量率照射和软琼脂克隆形成试验并不实用,因为这会降低放射敏感性测量数据获取的成功率。

相似文献

1
Discrimination of human tumor radioresponsiveness using low-dose rate irradiation.利用低剂量率照射鉴别人类肿瘤的放射反应性
Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):1147-53. doi: 10.1016/s0360-3016(98)00287-9.
2
Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.放射免疫疗法与体外及体内人肾细胞癌异种移植瘤外照射放疗的放射生物学研究。
Cancer. 1997 Dec 15;80(12 Suppl):2519-28. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2519::aid-cncr26>3.3.co;2-t.
3
Overview of radiosensitivity of human tumor cells to low-dose-rate irradiation.人类肿瘤细胞对低剂量率辐射的放射敏感性概述
Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):909-17. doi: 10.1016/j.ijrobp.2008.06.1928.
4
Radiosensitivity, repair capacity, and stem cell fraction in human soft tissue tumors: an in vitro study using multicellular spheroids and the colony assay.人类软组织肿瘤的放射敏感性、修复能力和干细胞比例:一项使用多细胞球体和集落测定法的体外研究
Int J Radiat Oncol Biol Phys. 1992;23(1):69-80. doi: 10.1016/0360-3016(92)90545-s.
5
Radiosensitivity of new and established human melanoma cell lines: comparison of [3H]thymidine incorporation and soft agar clonogenic assays.新的和已建立的人黑色素瘤细胞系的放射敏感性:[3H]胸苷掺入法和软琼脂克隆形成试验的比较
Eur J Cancer. 1994;30A(9):1370-6. doi: 10.1016/0959-8049(94)90188-0.
6
Potential application of the ATP cell viability assay in the measurement of intrinsic radiosensitivity in cervical cancer.ATP细胞活力测定法在宫颈癌内在放射敏感性测量中的潜在应用。
Gynecol Oncol. 2005 Mar;96(3):765-70. doi: 10.1016/j.ygyno.2004.11.025.
7
Robustness of Clonogenic Assays as a Biomarker for Cancer Cell Radiosensitivity.克隆集落形成分析作为癌症细胞放射敏感性生物标志物的稳健性。
Int J Mol Sci. 2019 Aug 25;20(17):4148. doi: 10.3390/ijms20174148.
8
Fractionated irradiation of five human lung cancer cell lines and prediction of survival according to a radiobiology model.分阶段照射五种人肺癌细胞系,并根据放射生物学模型预测生存情况。
Anticancer Res. 2011 Apr;31(4):1125-30.
9
Radiation survival of two human cervical carcinoma cell lines after multifraction irradiation.两种人宫颈癌细胞系在多次分割照射后的辐射存活情况。
Int J Radiat Oncol Biol Phys. 1996 Jul 15;35(5):941-50. doi: 10.1016/0360-3016(96)00144-7.
10
Differences in the level of DNA double-strand breaks in human tumour cell lines following low dose-rate irradiation.低剂量率照射后人肿瘤细胞系中DNA双链断裂水平的差异。
Eur J Cancer. 1992;28A(10):1610-4. doi: 10.1016/0959-8049(92)90052-4.

引用本文的文献

1
Dosimetric Evaluation of the Effect of Receptor Heterogeneity on the Therapeutic Efficacy of Peptide Receptor Radionuclide Therapy: Correlation with DNA Damage Induction and In Vivo Survival.受体异质性对肽受体放射性核素治疗疗效影响的剂量学评估:与 DNA 损伤诱导和体内生存的相关性。
J Nucl Med. 2022 Jan;63(1):100-107. doi: 10.2967/jnumed.121.262122. Epub 2021 Apr 9.
2
Influence of tumour size on the efficacy of targeted alpha therapy with (213)Bi-[DOTA(0),Tyr(3)]-octreotate.肿瘤大小对(213)Bi-[DOTA(0),Tyr(3)]-奥曲肽靶向α治疗疗效的影响
EJNMMI Res. 2016 Dec;6(1):6. doi: 10.1186/s13550-016-0162-2. Epub 2016 Jan 20.